Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2019 | Impact of gut mycobiota on outcomes after allo-HSCT

Mohamad Mohty • 7 Dec 2019
ASH 2019
General

Alterations of gut bacterial microbiota composition (mycobiota) have been associated with outcome after allogeneic hematopoietic stem cell transplantation (allo-HSCT), however the impact of the gut mycobiota is still unknown in the allo-HSCT setting. Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses a study that examined the role of fecal mycobiota in patients undergoing allo-HSCT. Prof. Mohty highlights the low fungal diversity in allo-HSCT patients and the future perspectives for this novel field of investigation. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

More from Mohamad Mohty

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:24
Comparing alloSCT outcomes in secondary and de-novo acute lymphoblastic leukemia
Mohamad Mohty • 15 Feb 2024
4:17
The evolving role of autoSCT in the age of CAR-T for multiple myeloma: current & future perspectives
Mohamad Mohty • 15 Feb 2024

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals